AASLD proudly recognizes the Department of Veterans Affairs (VA) Hepatitis Innovation Team (HIT) and the HIT collaborating offices with VA
ALEXANDRIA, Virginia — Each year, the American Association for the Study of Liver Diseases (AASLD) presents its most prestigious awards to recognize exceptional leadership, mentorship, service, and advocacy across the liver community.
AASLD proudly announces the Department of Veterans Affairs (VA) Hepatitis Innovation Team (HIT) and the HIT collaborating offices with VA as the 2025 Distinguished Advocacy Award Recipient. The award is being presented jointly to Dr. David Ross from the HIV and the Hepatitis and Related Conditions (HHRC) Program and Dr. Timothy Morgan from the National Gastroenterology and Hepatology Program (NGH).
The AASLD Distinguished Advocacy Award is given to an advocacy organization or individual in honor of sustained service to the liver disease community. The award recognizes service provided to the hepatology community over an extended period that raises awareness, garners public and federal legislative support, and promotes liver health and quality patient care.
“The Distinguished Advocacy Award reminds us all why advancing liver health is not only a scientific priority, but a public health imperative. We are honored to recognize the Department of Veterans Affairs Hepatitis Innovation Team and collaborating offices for their dedication and lasting impact on the hepatology community,” said AASLD Board President Grace L. Su, MD, FAASLD.
All awardees will be recognized and celebrated at the Awards & Honors Gala at The Liver Meeting (TLM), taking place Nov. 7–11, 2025 in Washington, D.C.
To learn more about the Distinguished Award recipients, click here.
For more information about TLM 2025 and the Awards & Honors Gala, please click here.
###
About AASLD
The American Association for the Study of Liver Diseases (AASLD) is the leading organization of scientists and health care professionals committed to preventing and curing liver disease. AASLD fosters research that leads to improved treatment options for millions of liver disease patients and advances the science and practice of hepatology through educational conferences, training programs, professional publications, and partnerships with government agencies and sister societies.